TY - JOUR AU - Singh, J. A. AU - Wells, G. A. AU - Christensen, R. PY - 2011 DA - 2011// TI - Adverse effects of biologics: a network meta-analysis and cochrane overview JO - Cochrane Database Syst Rev VL - 2 ID - Singh2011 ER - TY - JOUR AU - Chastek, B. AU - White, J. AU - Voorhis, D. AU - Tang, D. AU - Stolshek, B. S. PY - 2016 DA - 2016// TI - A retrospective cohort study comparing utilization and costs of biologic therapies and JAK inhibitor therapy across four common inflammatory indications in adult US managed care patients JO - Adv Ther VL - 33 UR - https://doi.org/10.1007/s12325-016-0312-y DO - 10.1007/s12325-016-0312-y ID - Chastek2016 ER - TY - CHAP AU - Brunton, L. L. AU - Chabner, B. A. AU - Knollmann, B. C. ED - Goodman ED - Gilman’s PY - 2011 DA - 2011// BT - The Pharmacological Basis of therapeutics PB - McGraw Hill CY - New York ID - Brunton2011 ER - TY - JOUR AU - Ternant, D. AU - Bejan-Angoulvant, T. AU - Passot, C. AU - Mulleman, D. AU - Paintaud, G. PY - 2015 DA - 2015// TI - Clinical pharmacokinetics and pharmacodynamics of monoclonal antibodies approved to treat rheumatoid arthritis JO - Clin Pharmacokinet VL - 11 UR - https://doi.org/10.1007/s40262-015-0296-9 DO - 10.1007/s40262-015-0296-9 ID - Ternant2015 ER - TY - BOOK AU - Rowland, M. AU - Tozer, T. N. PY - 2011 DA - 2011// TI - Clinical Pharmacokinetics and Pharmacodynamics PB - Wolters Kluwer CY - Philadelphia ID - Rowland2011 ER - TY - BOOK PY - 2010 DA - 2010// TI - Rapid Response Report: Preventing fatalities from medication loading doses ID - ref6 ER - TY - JOUR AU - Lamont, L. AU - Cousins, D. AU - Bischler, A. AU - Gerrett, D. PY - 2011 DA - 2011// TI - Safer loading doses of medicines: summary of a safety report from the National Patient Safety Agency JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d33 DO - 10.1136/bmj.d33 ID - Lamont2011 ER - TY - JOUR AU - Singh, J. A. AU - Cameron, C. AU - Noorbacloochi, S. PY - 2015 DA - 2015// TI - Risk of serious infection I biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis JO - Lancet VL - 18 ID - Singh2015 ER - TY - JOUR AU - Dirks, N. L. AU - Meibohm, B. PY - 2010 DA - 2010// TI - Population pharmacokinetics of therapeutic monoclonal antibodies JO - Clin Pharmacokinet VL - 49 UR - https://doi.org/10.2165/11535960-000000000-00000 DO - 10.2165/11535960-000000000-00000 ID - Dirks2010 ER - TY - JOUR AU - Takeuchi, T. AU - Yamamoto, K. AU - Yamanaka, H. PY - 2016 DA - 2016// TI - Post hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis JO - Mod Rheumatol VL - 26 UR - https://doi.org/10.3109/14397595.2015.1109182 DO - 10.3109/14397595.2015.1109182 ID - Takeuchi2016 ER - TY - CHAP AU - Schiff, M. AU - Alten, R. AU - Weinblatt PY - 2012 DA - 2012// TI - Weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without and intravenous abatacept loading dose BT - ACR / ARHP Annual meeting ID - Schiff2012 ER - TY - JOUR AU - Mease, P. AU - Genovese, M. C. AU - Gladstein, G. PY - 2011 DA - 2011// TI - Abatacept in the treatment of patients with psoriatic arthritis JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30176 DO - 10.1002/art.30176 ID - Mease2011 ER - TY - JOUR AU - Mease, P. AU - Heijde, D. AU - Landewé, R. PY - 2018 DA - 2018// TI - Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study JO - Ann Rheum Dis VL - 77 ID - Mease2018 ER - TY - JOUR AU - Kivitz, A. l. a. n. J. AU - Wagner, U. l. f. AU - Dokoupilova, E. v. a. AU - Supronik, J. e. r. z. y. AU - Martin, R. u. v. i. e. AU - Talloczy, Z. s. o. l. t. AU - Richards, H. a. n. n. o. B. AU - Porter, B. r. i. a. n. PY - 2018 DA - 2018// TI - Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study JO - Rheumatology and Therapy VL - 5 UR - https://doi.org/10.1007/s40744-018-0123-5 DO - 10.1007/s40744-018-0123-5 ID - Kivitz2018 ER - TY - JOUR AU - Ternant, D. AU - Ducourau, E. AU - Fuzibet, P. AU - Vignault, C. AU - Watier, H. AU - Leguerré, T. AU - Loët, X. AU - Vitecoq, O. AU - Goupille, P. AU - Mulleman, D. AU - Paintaud, G. PY - 2015 DA - 2015// TI - Pharmacokinetics and concentration-effect relationships of adalimumab in rheumatoid arthritis JO - Br J Clin Pharmacol VL - 79 UR - https://doi.org/10.1111/bcp.12509 DO - 10.1111/bcp.12509 ID - Ternant2015 ER - TY - JOUR AU - Yamamoto, K. AU - Takeuchi, T. AU - Yamanaka, H. PY - 2014 DA - 2014// TI - Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial JO - Mod Rheumatol VL - 24 UR - https://doi.org/10.3109/14397595.2013.843764 DO - 10.3109/14397595.2013.843764 ID - Yamamoto2014 ER - TY - JOUR AU - Karmiris, K. AU - Paintaud, G. AU - Noman, M. AU - Magdelaine-Beuzelin, C. AU - Ferrante, M. AU - Degenne, D. AU - Claes, K. AU - Coopman, T. AU - Schuerbeek, N. AU - Assche, G. AU - Vermeire, S. AU - Rutgeerts, P. PY - 2009 DA - 2009// TI - Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease JO - Gastroenterology. VL - 137 UR - https://doi.org/10.1053/j.gastro.2009.07.062 DO - 10.1053/j.gastro.2009.07.062 ID - Karmiris2009 ER - TY - JOUR AU - Gilbert, K. E. AU - Manalo, I. F. AU - Wu, J. J. PY - 2015 DA - 2015// TI - Efficay and safety of etanercept and adalimumab with and without loading dose for psoriasis; a systematic review JO - J Am Acad Dermatol VL - 73 UR - https://doi.org/10.1016/j.jaad.2015.04.012 DO - 10.1016/j.jaad.2015.04.012 ID - Gilbert2015 ER - TY - JOUR AU - Hanauer, S. B. AU - Sandborn, W. J. AU - Rutgeerts, P. AU - Fedorak, R. N. AU - Lukas, M. AU - MacIntosh, D. AU - Panaccione, R. AU - Wolf, D. AU - Pollack, P. PY - 2006 DA - 2006// TI - Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial JO - Gastroenterology VL - 130 UR - https://doi.org/10.1053/j.gastro.2005.11.030 DO - 10.1053/j.gastro.2005.11.030 ID - Hanauer2006 ER - TY - JOUR AU - Landewe, R. B. AU - Boers, M. AU - Verhoeven, A. C. PY - 2002 DA - 2002// TI - COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10083 DO - 10.1002/art.10083 ID - Landewe2002 ER - TY - JOUR AU - Martin, K. AU - Lott, S. PY - 2017 DA - 2017// TI - Dose creep and biologic therapies: pharmacists’ role in optimizing therapy JO - Pharmacy Today VL - 23 UR - https://doi.org/10.1016/j.ptdy.2017.09.040 DO - 10.1016/j.ptdy.2017.09.040 ID - Martin2017 ER -